News

The turmoil in Congress over the Jeffrey Epstein probe isn't going away anytime soon after the House Speaker ended the ...
Players are working to earn Johnson's trust, but he's working to do the same as he tries to end the Bears' run of fizzling ...
Speaker Mike Johnson said he would shut the House down early for the summer on Wednesday to head off Democrats’ calls for ...
Johnson & Johnson's stock offers value with promising MedTech growth, raised guidance, strong dividends, and bullish ...
Johnson says he wants to put social workers at stops and launch an anti-smoking campaign. A council member who’s pushed for ...
We recently published 10 Stocks Jim Cramer Discussed As He Shared Key Insights From Morgan Stanley’s CEO. Johnson & Johnson ...
Johnson & Johnson is partnering with Pacira BioSciences for osteoarthritis of the knee, according to a July 22 news release. The agreement adds Zilretta, an injectable osteoarthritis treatment, to ...
The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...